Innovative Research Award
Azar Tahghighi
Pasteur Institute of Iran
| Azar Tahghighi | |
|---|---|
| Affiliation | Pasteur Institute of Iran |
| Country | Iran |
| Scopus ID | 24923832500 |
| Documents | 47 |
| Citations | 728 |
| h-index | 15 |
| Subject Area | Others |
| Event | International Research Awards on Network Science & Graph Analytics |
| ORCID | 0000-0002-1221-4490 |
Azar Tahghighi is a researcher affiliated with the Pasteur Institute of Iran whose scientific contributions span medicinal chemistry, computational drug discovery, antimicrobial research, and molecular design. Through a combination of experimental and in silico methodologies, Tahghighi has participated in the development and evaluation of bioactive compounds targeting infectious diseases and immune-related pathways. The researcher’s publication record demonstrates sustained engagement with pharmaceutical innovation, molecular docking, virtual screening, and structure-based drug design approaches.[1]
Abstract
This article highlights the scholarly profile of Azar Tahghighi and evaluates the relevance of the researcher’s achievements for recognition under the Innovative Research Award category. The body of work encompasses medicinal chemistry, computational biology, antimicrobial discovery, and receptor-targeted molecular design. Published studies demonstrate interdisciplinary integration of laboratory validation and computational modeling, contributing to contemporary pharmaceutical and biomedical research.[2]
Keywords
Medicinal Chemistry, Molecular Docking, Drug Discovery, Antimicrobial Research, Virtual Screening, Biofilm Inhibition, Computational Biology, Pharmaceutical Sciences.
Introduction
Modern biomedical innovation increasingly relies on the integration of computational prediction and experimental validation. Azar Tahghighi’s research reflects this trend through studies focused on molecular interactions, therapeutic candidate identification, and biologically active compound optimization. Such work contributes to advancing drug development methodologies and addressing challenges associated with infectious diseases and immune modulation.[3]
Research Profile
The researcher has accumulated 47 indexed publications, 728 citations, and an h-index of 15. Research activities are characterized by multidisciplinary collaboration and a focus on translational applications. Areas of expertise include medicinal chemistry, receptor-based drug design, antimicrobial agents, computational pharmacology, and chemical biology.[1]
Research Contributions
- Development of triazoloquinoxaline derivatives as potential Toll-like receptor 7 ligands for immune modulation.[2]
- Application of pharmacophore-based virtual screening and molecular docking methodologies for candidate identification.[3]
- Investigation of antibacterial and antibiofilm agents targeting methicillin-resistant Staphylococcus aureus.[4]
- Advancement of green chemistry approaches for antifungal drug synthesis through click chemistry methodologies.[5]
Publications
- Structure-guided design of triazolo[4,3-a] quinoxaline-4-ol derivatives as novel TLR7 ligands (2026).
- Identification of new triazoloquinoxaline amine derivatives through virtual screening and docking approaches (2025).
- Antibacterial and antibiofilm efficacy of a synthetic nitrofuranyl pyranopyrimidinone derivative (2025).
- Click chemistry as a tool for green synthesis of antifungal medications (2024).
- Evaluation of antibacterial and antibiofilm activity of probiotic Lactobacillus extracts (2024).
Research Impact
The scientific contributions of Azar Tahghighi have supported advancements in drug discovery pipelines, particularly through the integration of computational screening tools with laboratory experimentation. The citation profile indicates sustained scholarly engagement, while publications in peer-reviewed journals reflect relevance across medicinal chemistry, microbiology, and pharmaceutical sciences. These outcomes contribute to knowledge generation and provide frameworks for future therapeutic development.[4][5]
Award Suitability
Azar Tahghighi demonstrates characteristics commonly associated with innovative scientific achievement, including interdisciplinary collaboration, methodological diversity, and practical relevance. The researcher’s work on receptor-targeted compounds, antimicrobial agents, and computational drug discovery illustrates a commitment to addressing contemporary biomedical challenges through evidence-based approaches. Such contributions align with the objectives of the International Research Awards on Network Science & Graph Analytics in recognizing impactful and forward-looking research accomplishments.
Conclusion
The academic record of Azar Tahghighi reflects sustained contributions to medicinal chemistry and biomedical research. Through a combination of computational and experimental methodologies, the researcher has participated in advancing scientific understanding of therapeutic design and antimicrobial discovery. The overall profile supports consideration for recognition within the Innovative Research Award category.
External Links
References
- Elsevier. (n.d.). Scopus author details: Azar Tahghighi, Author ID 24923832500. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=24923832500 - Tahghighi, A. (2026). Structure-guided design of triazolo[4,3-a] quinoxaline-4-ol derivatives as novel TLR7 ligands.
DOI: https://doi.org/10.1016/j.chphi.2026.101045 - Tahghighi, A. (2025). Identification of new triazoloquinoxaline amine derivatives through virtual screening and molecular docking.
DOI: https://doi.org/10.1371/journal.pone.0336701 - Tahghighi, A. (2025). Antibacterial and Antibiofilm Efficacy of a Synthetic Nitrofuranyl Pyranopyrimidinone Derivative.
DOI: https://doi.org/10.61882/JoMMID.13.2.139 - Tahghighi, A. (2024). Click chemistry beyond metal-catalyzed cycloaddition as a remarkable tool for green chemical synthesis of antifungal medications.
DOI: https://doi.org/10.1111/cbdd.14555 - Iranian Biomedical Journal. (2024). Evaluation of Anti-Bacterial and Anti-Biofilm Activity of Native Probiotic Strains of Lactobacillus Extracts.
DOI: https://doi.org/10.61186/ibj.4043